Toggle Main Menu Toggle Search

Open Access padlockePrints

Eculizumab allows plasma exchnage discontinuation after a third kidney transplantation in a patient with plasma dependent atypical hus due to CFH mutation

Lookup NU author(s): Dr Lisa Turnbull, Professor Tim Goodship


Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Publication metadata

Author(s): Davin JC, Gracchi V, Bouts AH, Groothoff JW, Strain L, Goodship T

Publication type: Article

Publication status: Published

Journal: Pediatric Nephrology

Year: 2009

Volume: 24

Issue: 9

Pages: 1881

ISSN (print): 0931-041X

ISSN (electronic): 1432-198X

Publisher: Springer no. M136


DOI: 10.1007/s00467-009-1250-6

Notes: 42nd Annual Scientific Meeting of the European Society for Paediatric Nephrology. A Joint Meeting with the Renal Association. 2-5 September 2009. University of Birmingham, UK.


Altmetrics provided by Altmetric